MedPath

Dexmedetomidine and Dexamethasone, Which is a better adjuvant with Ropivacaine in Adductor canal block?

Phase 2/3
Completed
Conditions
Medical and Surgical, (2) ICD-10 Condition: M239||Unspecified internal derangement of knee,
Registration Number
CTRI/2023/10/058472
Lead Sponsor
BLK Super Speciality Hospital
Brief Summary

This study is being conducted as part of Post Graduation Curriculum, Our aim is to compare  Dexmedetomidine and Dexamethasone as adjuvant to Ropivacaine in Ultrasounded guided  Adductor canal block for knee Arthroscopic surgeries. We are planning to include patients undergoing elective knee Arthroscopic surgeries under Sub Arachinoid block, who are American Society of Anaesthesiologists grade  I and II. We are intenting to finish the study in 18 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Elective knee arthroscopic surgeries under sub arachinoid block, giving consent to postoperative adductor canal block.
  • Age within 18 to 65, belonging to either gender.
  • American society of anaesthesiologists grade I and II.
Exclusion Criteria
  • Allergy to any of the drugs used.
  • Any contraindication to adductor canal block and Sub Arachinoid Block, like local infection.
  • History of diseases like diabetic neuropathy or any other neuropathy.
  • Any liver dysfunction or renal dysfunction.
  • Body mass index more than 35.
  • Patients who are on any anticoagulants or sedatives or having any deranged coagulation profile.
  • Pregnant females.
  • Patients with partial Sub Arachinoid Block, in need of additional analgesia during surgery.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of total analgesia duration.Total requirement of rescue analgesia over a period of 24 hours.
Secondary Outcome Measures
NameTimeMethod
PATIENT SATISFACTION SCOREEARLY TOE MOBILITY

Trial Locations

Locations (1)

BLK Super Speciality Hospital

🇮🇳

Delhi, DELHI, India

BLK Super Speciality Hospital
🇮🇳Delhi, DELHI, India
Dr Muhsina K
Principal investigator
9539888198
muhsinaasees@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.